 double-blind placebo-control cytogenet studi oral acyclovir patient recurr genit herp antiherp drug acyclovir break chromosom vitro millimolar concentr toxic dose rodent single-gen mutat recurr genit herp patient chromosom damag peripher lymphocyt acut chronic acyclovir therapi patient acyclovir recurr placebo recurr recurr equal group treatment double-blind normal volunt acyclovir-tr cultur addit control cytogenet analys enrol pretreat day acut acyclovir placebo treatment first postenrol recurr postacut end year studi postchron cell metaphas patient time point structur numer chromosom abnorm No cytogenet effect chronic acut oral acyclovir treatment rel control pretreat control placebo treatment